A detailed history of Cwm, LLC transactions in Genmab A/S stock. As of the latest transaction made, Cwm, LLC holds 1,302 shares of GMAB stock, worth $26,651. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,302
Previous 986 32.05%
Holding current value
$26,651
Previous $25,000 28.0%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$23.84 - $28.48 $7,533 - $8,999
316 Added 32.05%
1,302 $32,000
Q2 2024

Jul 09, 2024

BUY
$25.13 - $30.27 $2,538 - $3,057
101 Added 11.41%
986 $25,000
Q1 2024

Apr 05, 2024

SELL
$26.43 - $32.77 $294,535 - $365,188
-11,144 Reduced 92.64%
885 $26,000
Q4 2023

Feb 01, 2024

SELL
$27.94 - $35.44 $48,252 - $61,204
-1,727 Reduced 12.55%
12,029 $383,000
Q3 2023

Oct 11, 2023

BUY
$35.27 - $42.24 $26,769 - $32,060
759 Added 5.84%
13,756 $485,000
Q2 2023

Aug 03, 2023

BUY
$37.4 - $42.94 $97,165 - $111,558
2,598 Added 24.98%
12,997 $494,000
Q1 2023

Apr 28, 2023

BUY
$34.88 - $43.22 $100,000 - $123,911
2,867 Added 38.06%
10,399 $393,000
Q4 2022

Feb 01, 2023

SELL
$33.8 - $47.06 $50,699 - $70,590
-1,500 Reduced 16.61%
7,532 $319,000
Q3 2022

Oct 27, 2022

SELL
$31.52 - $373.61 $51,881 - $614,962
-1,646 Reduced 15.41%
9,032 $290,000
Q2 2022

Jul 28, 2022

SELL
$26.83 - $38.57 $72,360 - $104,023
-2,697 Reduced 20.16%
10,678 $347,000
Q1 2022

Apr 21, 2022

SELL
$30.95 - $39.68 $105,044 - $134,673
-3,394 Reduced 20.24%
13,375 $484,000
Q4 2021

Jan 31, 2022

SELL
$35.87 - $47.12 $121,455 - $159,548
-3,386 Reduced 16.8%
16,769 $663,000
Q1 2021

Sep 15, 2021

SELL
$30.92 - $44.4 $120,340 - $172,804
-3,892 Reduced 16.18%
20,155 $823,000
Q1 2021

Apr 27, 2021

BUY
$30.92 - $44.4 $120,340 - $172,804
3,892 Added 19.31%
24,047 $789,000
Q4 2020

Sep 15, 2021

SELL
$33.66 - $40.76 $24,403 - $29,551
-725 Reduced 3.47%
20,155 $823,000
Q4 2020

Jan 27, 2021

BUY
$33.66 - $40.76 $24,403 - $29,551
725 Added 3.6%
20,880 $849,000
Q3 2020

Sep 15, 2021

BUY
$33.07 - $38.68 $666,525 - $779,595
20,155 New
20,155 $823,000
Q3 2020

Oct 19, 2020

SELL
$33.07 - $38.68 $666,525 - $779,595
-20,155 Closed
0 $0
Q2 2020

Sep 15, 2021

BUY
$20.05 - $33.89 $404,107 - $683,052
20,155 New
20,155 $823,000
Q2 2020

Jul 22, 2020

SELL
$20.05 - $33.89 $404,107 - $683,052
-20,155 Closed
0 $0
Q1 2020

Sep 15, 2021

BUY
$17.15 - $25.22 $345,658 - $508,309
20,155 New
20,155 $823,000
Q1 2020

Apr 28, 2020

SELL
$17.15 - $25.22 $345,658 - $508,309
-20,155 Closed
0 $0
Q4 2019

Sep 14, 2021

BUY
$18.88 - $24.14 $380,526 - $486,541
20,155 New
20,155 $823,000
Q4 2019

Jan 27, 2020

SELL
$18.88 - $24.14 $380,526 - $486,541
-20,155 Closed
0 $0
Q3 2019

Sep 14, 2021

BUY
$18.0 - $21.38 $362,790 - $430,913
20,155 New
20,155 $823,000
Q3 2019

Oct 22, 2019

SELL
$18.0 - $21.38 $362,790 - $430,913
-20,155 Closed
0 $0
Q2 2019

Sep 14, 2021

BUY
$16.37 - $18.47 $329,937 - $372,262
20,155 New
20,155 $823,000
Q2 2019

Jul 31, 2019

SELL
$16.37 - $18.47 $329,937 - $372,262
-20,155 Closed
0 $0
Q1 2019

Sep 02, 2021

BUY
$14.53 - $17.93 $292,852 - $361,379
20,155 New
20,155 $0

Others Institutions Holding GMAB

About GENMAB A/S


  • Ticker GMAB
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 658,292,992
  • Market Cap $13.5B
  • Description
  • Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...
More about GMAB
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.